RANINasdaq United States
Market cap
$98.115 M
$0.79 +1.40%
Close of 7 Aug 2026
Revenue
$1.63M
#3459 by revenue
Earnings
-$29.7M
Loss-making
Shares outstanding
—
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Rani Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.